“39. SYSTEMATIC REVIEW OF THE EFFICARY, SAFETY AND COST-EFFECTIVENESS OF MIRABEGRON IN COMPARISON WITH SOLIFENACIN IN THE TREATMENT OF OVERACTIVE BLADDER”, YHCĐ, vol. 65, no. CĐ 7 - NCKH, July 2024, doi: 10.52163/yhc.v65iCD7.1334.